chr16-15771667-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 1P and 1B. PP2BP4
The NM_002474.3(MYH11):āc.935A>Gā(p.Asn312Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000397 in 1,613,960 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_002474.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH11 | NM_002474.3 | c.935A>G | p.Asn312Ser | missense_variant | 9/41 | ENST00000300036.6 | NP_002465.1 | |
MYH11 | NM_001040113.2 | c.956A>G | p.Asn319Ser | missense_variant | 10/43 | ENST00000452625.7 | NP_001035202.1 | |
MYH11 | NM_001040114.2 | c.956A>G | p.Asn319Ser | missense_variant | 10/42 | NP_001035203.1 | ||
MYH11 | NM_022844.3 | c.935A>G | p.Asn312Ser | missense_variant | 9/42 | NP_074035.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH11 | ENST00000300036.6 | c.935A>G | p.Asn312Ser | missense_variant | 9/41 | 1 | NM_002474.3 | ENSP00000300036 | P3 | |
MYH11 | ENST00000452625.7 | c.956A>G | p.Asn319Ser | missense_variant | 10/43 | 1 | NM_001040113.2 | ENSP00000407821 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152070Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251452Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135900
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461890Hom.: 0 Cov.: 32 AF XY: 0.0000454 AC XY: 33AN XY: 727248
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152070Hom.: 0 Cov.: 30 AF XY: 0.0000404 AC XY: 3AN XY: 74298
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Dec 06, 2022 | This missense variant replaces asparagine with serine at codon 319 of the MYH11 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in an individual affected with abdominal aortic aneurysm, but this variant did not segregate with disease in the family (PMID: 26017485). This variant has been identified in 13/282798 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 16, 2021 | The p.N312S variant (also known as c.935A>G), located in coding exon 8 of the MYH11 gene, results from an A to G substitution at nucleotide position 935. The asparagine at codon 312 is replaced by serine, an amino acid with highly similar properties. This variant (reported as c.956A>G, p.N319S) has been detected in a family reported to have abdominal aortic aneurysm; however, it was indicated to not segregate with disease (van de Luijtgaarden KM et al. Hum Genet, 2015 Aug;134:881-93). This variant co-occurred with a pathogenic alteration in the TGFBR1 gene in a family with thoracic aortic aneurysm or dissection. The TGFBR1 mutation segregated with disease in the family (Dong SB et al. Ann Vasc Surg, 2014 Nov;28:1909-12). This amino acid position is well conserved in available vertebrate species; however, serine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 05, 2019 | Reported as N319S (due to alternate nomenclature) in an individual with abdominal aortic aneurysm; however, no additional clinical information was available (van de Luijtgaarden et al., 2015); Reported in ClinVar as a variant of uncertain significance by other clinical laboratories (ClinVar Variant ID# 566653; Landrum et al., 2016); Observed in 13/282,798 (0.0046%) global alleles in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 26017485) - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jan 12, 2022 | The MYH11 c.935A>G; p.Asn312Ser variant (rs149964928), also known as p.Asn319Ser on an alternate transcript, is reported in an individual with abdominal aortic aneurysm, but did not segregate with disease in the family (van de Luijtgaarden 2015). The variant is listed in the ClinVar database (Variation ID: 566653) and is reported in the general population with an overall allele frequency of 0.005% (13/282798 alleles) in the Genome Aggregation Database. The asparagine at codon 312 is moderately conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.381). Due to limited information, the clinical significance of the p.Asn312Ser variant is uncertain at this time. References: van de Luijtgaarden KM et al. First genetic analysis of aneurysm genes in familial and sporadic abdominal aortic aneurysm. Hum Genet. 2015 Aug;134(8):881-93. PMID: 26017485. - |
Aortic aneurysm, familial thoracic 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 319 of the MYH11 protein (p.Asn319Ser). This variant is present in population databases (rs149964928, gnomAD 0.01%). This missense change has been observed in individual(s) with abdominal aneurysm (PMID: 26017485). ClinVar contains an entry for this variant (Variation ID: 566653). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt MYH11 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Aortic aneurysm, familial thoracic 4;C5543466:Visceral myopathy 2;C5543476:Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 24, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at